Company news
Genincode Plc (LSE:GENI) news
Genincode Plc news releases on 6ix. Latest, Sep 30, 2026: Holding(s) in Company
Press releases & updates
Holding(s) in Company
September 30, 2026
Half-year Financial Report
September 29, 2026
CARDIO inCode-Score milestone clinical results
August 28, 2026
Holding(s) in Company
February 26, 2026
Result of GM, Director Shareholdings and TVR
February 9, 2026
Additional Subscription
February 6, 2026
Result of Retail Offer
January 26, 2026
Result of Placing and Subscription
January 22, 2026
Retail Offer
January 21, 2026
Placing and Subscription
January 21, 2026
Collaboration with Sohin Genetics
December 17, 2025
Collaboration with Thermo Fisher
December 4, 2025
Approval of CARDIO inCode-score in New York state
December 3, 2025
New Study From GENinCode Shows Polygenic Risk Scores Improve the Accuracy of Cardiovascular Disease Risk Prediction
November 12, 2025
Publication of Landmark Study in JACC: Advances
October 28, 2025
Half-year Report
September 30, 2025
NHS (UCLH) Risk of Ovarian Cancer (ROCA) launch
September 25, 2025
Stmnt re Share Price Movement
September 17, 2025
Notice of Results
September 5, 2025
Trading update
August 26, 2025
De Novo Update – FDA Supervisory Review
July 7, 2025
Result of AGM
June 30, 2025
Final Results
June 4, 2025
De Novo Submission Update
April 30, 2025
Grant of Share Options & PDMR Dealings
March 26, 2025
Result of General Meeting, Issue of Equity and TVR
March 3, 2025
CARDIO inCode Lab Fee Update & Catalonia Launch
January 23, 2025
Partnership with Genesupport SA for the ROCA® Test
December 10, 2024
CARDIO inCode® publication & Trading Update
December 5, 2024
Collaboration with The Family Heart Foundation
September 20, 2024
CARDIO inCode-Score presentation
August 28, 2024
Posting of Annual Report and Notice of AGM
June 5, 2024
Grant of Options & Surrender of Existing Options
April 26, 2024
CARDIO inCode-Score® US study publication
April 4, 2024
New NICE Guidance for Ovarian Cancer
March 21, 2024
Result of GM and Total Voting Rights
January 9, 2024
CARDIO inCode-Score 510(k) FDA submission update
November 29, 2023
Change of Adviser
November 29, 2023
ShareSoc investor presentation
October 12, 2023
Presentation at European Society of Cardiology
August 30, 2023
CARDIO inCode 510k filing
August 16, 2023
Collaboration with US healthcare provider
July 19, 2023
Notice of AGM and posting of Annual Report
June 8, 2023
CARDIO inCode be presented at conference
May 22, 2023
Collaboration with University Clinic Dresden
May 15, 2023
NHS LIPID inCode testing implementation
May 2, 2023
CARDIO InCode CPT PLA Code
April 3, 2023
Statement re: Silicon Valley Bank
March 13, 2023
Second Price Monitoring Extn
January 3, 2023
Price Monitoring Extension
January 3, 2023